Pay-for-delay ruling exposes uncertainty in EU law
The Paroxetine judgment in the UK highlights a slew of questions that the EU courts have yet to resolve about patent settlements, and takes issue with the UK competition enforcer’s reasoning on market definitions. Tom Webb scrutinises the ruling
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.